艾美捷科技特约代理F.S.T（Fine Science Tools）公司全系列产品。

F.S.T（Fine Science Tools）公司以追求高质量的产品和优质的服务为目标，为医护和科研人员提供医疗和动物精密手术器械，因而成为全球领先的手术器械生产商和供应商。F. S. T拥有手术剪、手术镊、骨科器械、手术刀及刀片、血管钳、持针钳等10余类共1000余种。

Fine Science Tools is the leading distributor of precision European surgical and microsurgical instruments to the scientific and biomedical research community.

Fine Science Tools公司的主要产品包括：

Scissors

Bone Instruments

Scalpels & Blades

Curettes, Spatulae & Probes

Pins

Wound Closure

Retractors

Vascular Instruments

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技特约代理Bethyl Laboratories全系列产品。

Bethyl Laboratories公司是世界著名的一抗和二抗生产商，成立于1972年，美国农业部(USDA)认证企业,符合GMP标准。致力于给研究者提供高品质抗体。主要生产抗体为细胞生物学类。公司为临床和科研提供高品质的抗体生产和服务，拥有世界上最丰富的细胞凋亡产品。如：凯氏半胱氨酸蛋白酶分析试剂盒和试剂，细胞凋亡检测试剂盒及试剂，与细胞凋亡相关的抗体，细胞增殖和细胞毒性检测试剂盒，生长因子，细胞因子和趋化因子，分子生物学试剂盒及试剂等研究产品。此外，该公司生产的各种动物免疫球蛋白的elisa试剂盒，规格一般为10x96T，性价比优越，颇受广大科研工作者的亲睐。

Bethyl Laboratories, Inc. has been dedicated to supporting scientific discovery through its qualified antibody products and custom polyclonal antibody services since its founding in 1972. With over 45 years of experience, Bethyl is also a leading provider of custom polyclonal antibody production services. Bethyl offers complete packages from initial peptide synthesis to affinity purification of custom polyclonal antibodies from an antigen-specific immunosorbent. Most recently, our capabilities have expanded and we now offer contract recombinant rabbit monoclonal antibody partnerships.

Bethyl Laboratories公司的主要产品包括：

Cell Lysate Preparation

Western Blot (WB)

Immunoprecipitation

Immunohistochemistry (IHC)

ELISA

Proximity Ligation Assay (PLA)

Flow Cytometry

Dilutions

Terms and Abbreviations

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.